Virax Biolabs Group Ltd 20-F for FY2026
Virax Biolabs Group Ltd (VRAX)
20-F
2026-07-06
For: 2026-03-31
View Original
Added on
July 07, 2026
About this 20-F
Virax Biolabs Group Ltd filed this 20-F on July 6, 2026, covering the fiscal year ended March 31, 2026 (FY2026).
Headline figures
Fiscal year ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $12.42K
- up 96.2% from $6331 a year earlier
- Net loss
- $5.02M
- compared with a net loss of $6.06M a year earlier
- Diluted EPS
- -$12.64
- compared with -$40.62 a year earlier